| 2025 | Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosis
| NATURE COMMUNICATIONS |
| 2025 | Adjunctive beneficial effect of c-di-GMP, a STING agonist, in enhancing protective efficacy of TLR4-adjuvanted tuberculosis subunit vaccine formulations
| JOURNAL OF BIOMEDICAL SCIENCE |
| 2024 | Permissive lung neutrophils facilitate tuberculosis immunopathogenesis in male phagocyte NADPH oxidase-deficient mice
| PLOS PATHOGENS |
| 2024 | BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice
| NPJ VACCINES |
| 2024 | Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains | VACCINE |
| 2023 | Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications
| VACCINE: X |
| 2023 | Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection
| IMMUNE NETWORK |
| 2022 | BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
| SCIENTIFIC REPORTS |
| 2022 | Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2022 | Host-directed anti-mycobacterial activity of colchicine, an anti-gout drug, via strengthened host innate resistance reinforced by the IL-1β/PGE 2 axis | BRITISH JOURNAL OF PHARMACOLOGY |
| 2022 | Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx
| NATURE COMMUNICATIONS |
| 2021 | Exacerbation of Mycobacterium avium pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses
| VIRULENCE |
| 2020 | Antigen-Specific IFN-γ/IL-17-Co-Producing CD4 + T-Cells Are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine
| VACCINES |
| 2020 | Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent Mycobacterium tuberculosis K infection
| VIRULENCE |
| 2020 | Plant-Produced N-glycosylated Ag85A Exhibits Enhanced Vaccine Efficacy Against Mycobacterium tuberculosis HN878 Through Balanced Multifunctional Th1 T Cell Immunity
| VACCINES |
| 2020 | Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis | VACCINE |
